Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

BOND Ready-To-Use Primary Antibody CDX2 (EP25) Recalled by Leica Microsystems, Inc. Due to Product may not perform as specified in IFU.

Date: July 30, 2021
Company: Leica Microsystems, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Leica Microsystems, Inc. directly.

Affected Products

BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375

Quantity: 237 units

Why Was This Recalled?

Product may not perform as specified in IFU.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Leica Microsystems, Inc.

Leica Microsystems, Inc. has 40 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report